Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice

Loading...
Thumbnail Image
Issue Date
2005
Authors
Medical Center Staff
Publisher
Stony Brook Medicine, Stony Brook University